Home › Funds › Millennium Management › TRAW
Millennium Management position in TRAW
TRAWS PHARMA INC · Health Care
Latest position (Q1 2025)10.07K sh
Reported value held$23.16K
Portfolio Weight0.00%
First reportedQ4 2021
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2021 | 13.55K | $35.00K | New |
| Q1 2022 | 24.11K | $44.00K | Add |
| Q2 2022 | 61.39K | $81.00K | Add |
| Q3 2022 | 59.23K | $52.00K | Reduce |
| Q4 2022 | 30.45K | $20 | Reduce |
| Q2 2023 | 12.72K | $15.01K | New |
| Q3 2023 | 11.65K | $8.41K | Reduce |
| Q4 2023 | 15.49K | $11.55K | Add |
| Q4 2024 | 10.01K | $88.91K | New |
| Q1 2025 | 10.07K | $23.16K | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding TRAW
- Vanguard Group 87.26K sh · $98.60K · Q4 2025
- Geode Capital Management 111.36K sh · $93.92K · Q2 2026
- Northern Trust Corp 37.45K sh · $31.59K · Q2 2026
- BlackRock Inc 9.94K sh · $8.38K · Q2 2026
- UBS Group AG 3.45K sh · $2.91K · Q2 2026
- Morgan Stanley 468 sh · $395 · Q2 2026
- Fidelity Management & Research (FMR) 2 sh · $2 · Q2 2026